Intellectual Property India Publishes Patent Application for 2-(4-(2-(7, 8-Dimethyl-[1,2,4]triazolo[1,5-A] Pyridin-6-Yl)-3-Isopropyl-1h-Indol-5-Yl)piperidin-1- Yl)acetamide Salt And Crystalline Forms Thereof

MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202617054667 A) filed by Bristol-Myers Squibb Company on April 29, 2026, for 2-(4-(2-(7, 8-Dimethyl-[1,2,4]triazolo[1,5-A] Pyridin-6-Yl)-3-Isopropyl-1h-Indol-5-Yl)piperidin-1- Yl)acetamide Salt And Crystalline Forms Thereof.

Inventors include Kameshwar, Prashant Mrityunjaya Sujata; Narasimhamurthy, Roopa; Gao, Qi; and Nelson, Jennifer.

The application for the patent was published on August 07, 2026, under issue no. 32/2026.

Abstract: Disclosed are salts of 2?(4?(2?(7,8?dimethyl?[1,2,4]triazolo[1,5?a] pyridin?6?yl)?3?isopropyl?1H?indol?5?yl)piperidin?1?yl)acetamide and crystalline forms thereof.

Disclaimer: Curated by HT Syndication.